Balyasny Asset Management L.P. Buys Shares of 14,779 HealthEquity, Inc. (NASDAQ:HQY)

Balyasny Asset Management L.P. bought a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 14,779 shares of the company’s stock, valued at approximately $1,418,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity in the 4th quarter valued at approximately $26,000. Transce3nd LLC purchased a new stake in shares of HealthEquity in the 4th quarter valued at approximately $29,000. Smartleaf Asset Management LLC raised its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new stake in shares of HealthEquity in the 4th quarter valued at approximately $39,000. Finally, UMB Bank n.a. raised its stake in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Trading Up 0.3%

Shares of NASDAQ:HQY opened at $96.99 on Wednesday. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The company’s 50 day moving average is $87.82 and its two-hundred day moving average is $96.81. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.39 billion, a PE ratio of 88.98, a P/E/G ratio of 1.60 and a beta of 0.45.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their price target for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. The Goldman Sachs Group cut their target price on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. Barrington Research reaffirmed an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. KeyCorp cut their target price on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 16th. Finally, Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $111.75.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now directly owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.